- AstraZeneca is one of the world's leading pharmaceutical companies, with a broad range of medicines designed to fight disease in important areas of healthcare
- Backed by strong science and wide-ranging commercial skills, we are committed to sustainable development of our business and the delivery of a flow of new medicines that make a difference in the lives of patients and create value for our shareholders and wider society.
- We focus our resources on six therapy areas where we believe our skills and resources can make the most difference. These areas include some of the world's most serious illnesses and together represent a major worldwide burden of disease: cancer, cardiovascular, gastrointestinal, infection, neuroscience and respiratory & inflammation.
- Our broad product portfolio includes many world leaders and a number of high potential growth products: Arimidex (cancer), Crestor (cardiovascular), Nexium (gastrointestinal disease), Seroquel (schizophrenia) and Symbicort (asthma and chronic obstructive pulmonary disease).
- Active in over 100 countries with growing presence in important emerging markets; corporate office in London UK; major R&D sites in Sweden, the UK and the US.
- Sales in 2006 totalled $26.5 billion, with an operating profit of $8.2 billion.
- We are committed to continued top tier financial performance alongside continued innovation - from our own research laboratories and by accessing scientific innovation outside AstraZeneca.
- We spend over $16 million every working day on the research and development of new medicines that meet patient needs. (Total R&D spend in 2006: $3.9 billion).
- We employ around 12,000 people at 16 research and development centres in 8 countries.
- We have 27 manufacturing sites in 19 countries.
- Over 66,000 employees (58% in Europe, 27% in the Americas and 15% in Asia, Africa and Australasia).
- We combine our global capabilities with high quality relationships in local markets and focus on responding quickly and effectively to changing business needs.
- With a global business comes a global responsibility and, along with our commitment to competitiveness and performance, we will continue to be led by our core values to achieve sustainable success.
|
|
